[Cancer Management and Research] This network meta-analysis seeks to establish the optimal treatment in advanced nasopharyngeal carcinoma (NPC).
High pretreatment uric acid may be a clinical biomarker for lung metastasis.
Gemcitabine in combination with cisplatin is associated with a significant improvement in progression-free survival in nasopharyngeal carcinoma.
Patients with allergic rhinitis may have an increased risk of developing nasopharyngeal carcinoma (NPC), according to a study.
Patients with allergic rhinitis may have an increased risk of developing nasopharyngeal carcinoma.
A team of scientists from Singapore has identified a distinct mutational signature and nine mutated genes associated with nasopharyngeal cancer.
A team of scientists have discovered a distinct mutational signature and nine significantly mutated genes associated with nasopharyngeal cancer, paving the way to developing targeted therapies.
Patients with locally advanced nasopharyngeal cancer (NPC) do not benefit from the addition of neoadjuvant gemcitabine, carboplatin, and paclitaxel (GCP) to cisplatin chemoradiation.
A cancer patient was detained for four hours by immigration officials in the US because one of his cancer drugs had caused his fingerprints to disappear.
